Director · Dianthus Therapeutics, Inc. /DE/ · Common Stock
Side
SELL
Value
$2.15M
Shares
27.6K
Price
$78.05
Executed
Mar 24, 2026
Disclosed
Mar 26, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 24 executedMar 26, 2026 disclosed
DNTH · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Soteropoulos Paula filed this Form 4 reporting a open-market sale of DNTH on Mar 24, 2026. It became public on Mar 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Soteropoulos Paulacik:0001692444
Issuer
Dianthus Therapeutics, Inc. /DE/cik:0001690585
Revision history · 0
No field has changed since this record was first ingested.
